MyFinsight
Home
Blog
About
Net (decrease)
increase in cash and...
-$4,029K
(-290.86%↓ Y/Y)
Non-cash stock-based
compensation
$352K
(-80.29%↓ Y/Y)
Depreciation and
amortization
$255K
(-50.10%↓ Y/Y)
Prepaid expenses and
other current assets
-$181K
(80.81%↑ Y/Y)
Short-term operating lease
liabilities
$142K
(-36.89%↓ Y/Y)
Amortization of operating
lease right-of-use...
$140K
(-66.35%↓ Y/Y)
Accrued expenses and
other current...
$80K
(119.42%↑ Y/Y)
Amortization of finance lease
right-of-use assets
$62K
(-88.21%↓ Y/Y)
Other non-current
assets
-$27K
something is missing
$1,884K
Payment of issuance
costs from december...
-$11K
Net cash used in
operating activities
-$3,745K
(46.87%↑ Y/Y)
Net cash used in
investing activities
-$233K
Net cash (used in)
provided by financing...
-$51K
(-100.56%↓ Y/Y)
Canceled cashflow
$1,239K
Canceled cashflow
$1,895K
Net loss
-$4,781K
(55.08%↑ Y/Y)
Purchases of property and
equipment
$233K
Proceeds from the
exercise of series c...
-$1,884K
(-200.00%↓ Y/Y)
Long-term operating lease
liabilities
-$198K
(49.23%↑ Y/Y)
Accounts payable
-$5K
(50.00%↑ Y/Y)
Principal payments on
financing leases
$62K
(-86.49%↓ Y/Y)
Back
Back
Cash Flow
IN8BIO, INC. (INAB)
IN8BIO, INC. (INAB)
source: myfinsight.com